Design and Evaluation of Novel Bi-Layer Tablet Technology: A Review

Abstract

Bi?layer tablets are advanced pharmaceutical dosage forms designed to deliver two drugs or two different drug release patterns within a single tablet. This technology helps improve therapeutic effectiveness, patient compliance, and drug stability. Conventional oral dosage forms sometimes produce fluctuations in drug concentration, which may reduce treatment effectiveness. Bi?layer tablet systems help overcome this limitation by providing immediate release in one layer and sustained or controlled release in another layer. This review article explains the concept of bi?layer tablet technology in simple language. It includes advantages, disadvantages, manufacturing process, types of tablet presses, challenges in production, evaluation tests, modern technologies, and applications. Bi?layer tablets are widely used for diseases such as hypertension, diabetes, pain, and infections. The article also discusses important evaluation parameters and quality requirements required for manufacturing high?quality bilayer tablets.

Keywords

Introduction

The oral route is the most commonly used method of drug administration because it is convenient, safe, and economical. Tablets are the most popular dosage forms due to their stability, accuracy of dose, and ease of manufacturing. However, conventional tablets release drug immediately after administration, which may cause sudden increase and rapid decrease in drug concentration in the body. [1–3].

To overcome these limitations, modified drug delivery systems were developed. One such system is the bi?layer tablet. A bi?layer tablet contains two layers that may contain either two different drugs or the same drug in different release forms. One layer may release the drug immediately while the second layer releases the drug slowly over a longer period of time. This approach improves therapeutic effect and reduces dosing frequency [4].

Bi?layer tablets are commonly used in combination therapy. For example, drugs used in diabetes treatment such as metformin and glimepiride are often formulated as bilayer tablets. Similarly, pain relief drugs and antihypertensive drugs can also be combined using this technology [5].

Fig.1: Bilayer Tablet Structure

2. Concept of Bi?Layer Tablets

A bi?layer tablet consists of two layers compressed together in a single tablet. Each layer has a specific function. The first layer may provide an immediate dose of drug, while the second layer provides sustained or controlled release.

The main purpose of developing bilayer tablets includes:

• Separation of incompatible drugs
• Sequential drug release
• Combination therapy
• Controlled drug delivery

This design allows the formulator to control the release profile of the drug and improve patient compliance [6].

3. Advantages of Bi?Layer Tablets

• Provides two drugs in one dosage form
• Reduces dosing frequency
• Improves patient compliance
• Allows separation of incompatible drugs
• Enables controlled and sustained drug release
• Provides better therapeutic effect
• Suitable for combination therapy
• Improves stability of drugs
• Suitable for large?scale manufacturing

4. Disadvantages of Bi?Layer Tablets

Manufacturing process is complex

• Risk of layer separation during compression
• Requires special equipment
• Formulation process is difficult
• Some drugs are difficult to compress

5. Ideal Characteristics of Bi?Layer Tablets

An ideal bilayer tablet should have the following characteristics:

• Uniform weight and thickness
• Adequate mechanical strength
• Good hardness
• Low friability
• Predictable drug release profile
• Physical and chemical stability
• Free from cracks, chips, or discoloration

6. Manufacturing Process

The manufacturing of bilayer tablets involves multiple steps. First, powders of both layers are prepared separately. The powder of the first layer is filled into the die cavity and compressed lightly. After that, the powder of the second layer is added and final compression is applied to form the bilayer tablet.

Key steps involved:

1. Weighing and mixing of ingredients
2. Granulation
3. Drying and lubrication
4. First layer compression
5. Second layer compression
6. Final bilayer tablet formation

Step 1: Powder Preparation

Each layer prepared separately:

• Drug
• Binder
• Diluent
• Lubricant

Step 2: Granulation

Improves powder flow.

Types:

• Wet granulation
• Dry granulation
• Direct compression

Step 3: First Layer Filling

Powder of first layer filled into die cavity.

Step 4: Pre-Compression

Light compression forms initial layer.

Purpose:

• Maintain structure

Allow bonding with second layer

Proper compression force is required to ensure strong bonding between the two layers[7].

Fig.2: Bilayer Tablet Manufacturing Process

7. Types of Bilayer Tablet Press

Different machines are used for manufacturing bilayer tablets.

Single?Sided Tablet Press This is the simplest machine used for bilayer tablet production. It compresses two layers sequentially in one die cavity. Double?Sided Tablet Press
This machine provides better weight control and improved production efficiency. Bilayer Tablet Press with Displacement Monitoring This is an advanced system that monitors punch displacement to maintain tablet weight and hardness [8].

Fig.3: Types of Bilayer Tablet Press

8. Challenges in Manufacturing

Although bilayer tablets provide many advantages, several manufacturing problems may occur.

Common challenges include:

• Weight variation
• Capping and lamination
• Low hardness
• Picking and sticking
• Layer separation
• Mottling

These problems can be minimized by optimizing formulation composition, compression force, and machine parameters [9].

9. Evaluation Tests

Quality control tests are performed to ensure the quality of bilayer tablets.

Thickness Test

Measured using a vernier caliper.

Hardness Test

Determines resistance to mechanical stress.

Friability Test

Measures tablet strength during transportation.

Weight Variation Test

Ensures uniform distribution of drug.

Disintegration Test

Determines time required for tablet to break down.

Stability Studies

Performed according to ICH guidelines to evaluate shelf life [10].

10. Modern Bilayer Tablet Technologies

Several advanced technologies are used in bilayer tablet formulation.

OROS Push?Pull Technology

Uses osmotic pressure to release drugs at controlled rate.

L?OROS Technology

Improves solubility of poorly soluble drugs.

DUREDAS Technology

Allows immediate and sustained release in a single tablet.

DUROS Technology

Used for long?term drug delivery systems [11].

Fig.4: Bilayer Drug Release Profile

11. Applications

Bilayer tablets are widely used in pharmaceutical therapy.

Examples include:

• Diabetes treatment (Metformin + Glimepiride)
• Hypertension therapy
• Pain management
• Antibacterial therapy
• Neurological disorders

These tablets help improve treatment effectiveness and reduce the number of doses
required per day [12].

CONCLUSION

Bi?layer tablet technology is an important advancement in pharmaceutical drug delivery.
It allows two drugs or two release profiles to be combined into a single tablet. This improves therapeutic effectiveness, patient compliance, and drug stability. Although manufacturing challenges exist, modern formulation techniques and advanced tablet presses allow production of high?quality bilayer tablets. Therefore, bilayer tablet technology will continue to play an important role in future pharmaceutical research and development.

REFERENCES

1. Rathore R, Gupta AK, Parashar AK. Formulation and Evaluation of fast dissolving films of Granisetron Hydrochlo ride. J Drug Delivery and Therapeutics. 2019; 9(2-A):36-38.
2. Gaikwad SS, Chafle SA, Morris PS, Avari JG. Development and evaluation of bilayer tablets of combination of antibiotics for the treatment of sexually transmitted disease. Brazilian Journal of Pharmaceutical Sciences [Internet]. 2016 Sep [cited 2022 Jan 11]; (3):555–66. Available from: http://dx.doi.org/10.1590/s1984-825020160 00300020.
3. Davis JR. Handbook of materials for medical devices. ASM International; 2003.
4. Malviya Y, Kondalkar A. Formulation development and evaluation of gastroretentive floating tablets of ambroxol hydrochloride. JDDT [Internet]. 23Nov. 2019; 9(4-s):1016-21.
5. Sangeetha R, Pillai MK, Haribabu Y. Bilayer tablets: A flexible technology for oral drug delivery-An updated review. Res J Pharm Technol [Internet]. 2021; 14(1):547– 51. Available from: http://dx.doi.org/10. 5958/0974-360x.2021.00099.8
6. Singh A, Das S, Gupta S, Ghosh S. The challenges of producing bilayer tablet: A review. J Drug Deliv Ther [Internet]. 2021; 11(4- S):171–5. Available from: http://dx. doi.org/10.22270/jddt.v11i4- s.4922.
7. Patra CN, Kumar AB, Pandit HK, Singh SP, Devi MV. Design and evaluation of sustained release bilayer tablets of proprano lol hydrochloride. Acta Pharm [Internet]. 2007; 57(4):479–89. Available from: http:// dx.doi.org/10.2478/v10007-007-0038-0.
8. Joseph D, Thomas GM. A review on current applications of bilayer tablets. Res J Pharm Technol [Internet]. 2019; 12(5):25 39. Available from: http://dx.doi.org/10.595 8/0974- 360x.2019.00427.x
9. Parashar AK, Patel P, Gupta AK, Jain NK, Kurmi BD. Synthesis, characterization andin vivoEvaluation of PEGylated PPI dendrimer for safe and prolonged delivery of insulin. Drug Deliv Lett. 2019; 9(3):248– 63.
10. Akhtar M, Jamshaid M, Zaman M, Mirza AZ. Bilayer tablets: A developing novel drug delivery system. J Drug Deliv Sci Technol [Internet]. 2020; 60(102079): 102079. Available from: http://dx.doi.org/1 0.1016/j.jddst.2020.102079
11. Agiba AM, Abul-Ella SS, El-Monem RAA. Pharmacotechnical development and optimization of multilayered tablets: An updated industrial review with emphasis on bilayer tablets. Int j appl pharm [Internet]. 2021; 55–64. Available from: http://dx.doi. org/10.22159/ijap.2021v13i4.41528
12. Kalra S, Kalra B, Agrawal N. Combination therapy in hypertension: An update. Diabetol Metab Syndr [Internet]. 2010; 2(1):44. Available from: http://dx.doi.org/ 10.1186/1758-5996-2-44